{"id":"https://openalex.org/W4396977424","doi":"https://doi.org/10.1080/14656566.2024.2356254","title":"Oral glucagon-like peptide-1 receptor agonists and combinations of entero-pancreatic hormones as treatments for adults with type 2 diabetes: where are we now?","display_name":"Oral glucagon-like peptide-1 receptor agonists and combinations of entero-pancreatic hormones as treatments for adults with type 2 diabetes: where are we now?","alternate_titles":[],"publication_year":2024,"publication_date":"2024-05-02","ids":{"openalex":"https://openalex.org/W4396977424","doi":"https://doi.org/10.1080/14656566.2024.2356254","pmid":"https://pubmed.ncbi.nlm.nih.gov/38753454","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11195668"},"language":"en","primary_location":{"id":"doi:10.1080/14656566.2024.2356254","doi":"https://doi.org/10.1080/14656566.2024.2356254","is_oa":true,"landing_page_url":"https://doi.org/10.1080/14656566.2024.2356254","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/14656566.2024.2356254","source":{"id":"https://openalex.org/S52020611","display_name":"Expert Opinion on Pharmacotherapy","issn_l":"1465-6566","issn":["1465-6566","1744-7666"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Pharmacotherapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4396977424"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.tandfonline.com/doi/pdf/10.1080/14656566.2024.2356254","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069898671","display_name":"Prathima Gogineni","orcid":"https://orcid.org/0000-0003-2786-731X","observed_orcids":["https://orcid.org/0000-0003-2786-731X"]},"institutions":[{"id":"https://openalex.org/I153648349","display_name":"University of Leicester","ror":"https://ror.org/04h699437","country_code":"GB","type":"education","lineage":["https://openalex.org/I153648349"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Prathima Gogineni","raw_affiliation_strings":["Diabetes Research Centre, University of Leicester College of Life Sciences, Leicester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diabetes Research Centre, University of Leicester College of Life Sciences, Leicester, UK","institution_ids":["https://openalex.org/I153648349"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005166583","display_name":"Eka Melson","orcid":"https://orcid.org/0000-0003-0685-4819","observed_orcids":["https://orcid.org/0000-0003-0685-4819"]},"institutions":[{"id":"https://openalex.org/I153648349","display_name":"University of Leicester","ror":"https://ror.org/04h699437","country_code":"GB","type":"education","lineage":["https://openalex.org/I153648349"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Eka Melson","raw_affiliation_strings":["Diabetes Research Centre, University of Leicester College of Life Sciences, Leicester, UK"],"raw_orcid":"https://orcid.org/0000-0003-0685-4819","affiliations":[{"raw_affiliation_string":"Diabetes Research Centre, University of Leicester College of Life Sciences, Leicester, UK","institution_ids":["https://openalex.org/I153648349"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017193412","display_name":"Dimitris Papamargaritis","orcid":"https://orcid.org/0000-0001-5044-1515","observed_orcids":["https://orcid.org/0000-0001-5044-1515"]},"institutions":[{"id":"https://openalex.org/I153648349","display_name":"University of Leicester","ror":"https://ror.org/04h699437","country_code":"GB","type":"education","lineage":["https://openalex.org/I153648349"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Dimitris Papamargaritis","raw_affiliation_strings":["Diabetes Research Centre, University of Leicester College of Life Sciences, Leicester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diabetes Research Centre, University of Leicester College of Life Sciences, Leicester, UK","institution_ids":["https://openalex.org/I153648349"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5084593004","display_name":"Melanie Jane Davies","orcid":"https://orcid.org/0000-0002-9987-9371","observed_orcids":["https://orcid.org/0000-0002-9987-9371"]},"institutions":[{"id":"https://openalex.org/I153648349","display_name":"University of Leicester","ror":"https://ror.org/04h699437","country_code":"GB","type":"education","lineage":["https://openalex.org/I153648349"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Melanie Davies","raw_affiliation_strings":["Diabetes Research Centre, University of Leicester College of Life Sciences, Leicester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diabetes Research Centre, University of Leicester College of Life Sciences, Leicester, UK","institution_ids":["https://openalex.org/I153648349"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5017193412"],"corresponding_institution_ids":["https://openalex.org/I153648349"],"apc_list":null,"apc_paid":null,"fwci":1.5253,"has_fulltext":true,"cited_by_count":38,"citation_normalized_percentile":{"value":0.85122075,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"25","issue":"7","first_page":"801","last_page":"818"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8809999823570251},{"id":"https://openalex.org/keywords/oral-glp-1-receptor-agonists","display_name":"oral GLP-1 receptor agonists","score":0.9679999947547913},{"id":"https://openalex.org/keywords/semaglutide","display_name":"semaglutide","score":0.7889999747276306},{"id":"https://openalex.org/keywords/orforglipron","display_name":"orforglipron","score":0.9940000176429749},{"id":"https://openalex.org/keywords/tirzepatide","display_name":"tirzepatide","score":0.9900000095367432},{"id":"https://openalex.org/keywords/cagrilintide","display_name":"cagrilintide","score":0.843999981880188},{"id":"https://openalex.org/keywords/survodutide","display_name":"survodutide","score":0.9629999995231628},{"id":"https://openalex.org/keywords/mazdutide","display_name":"mazdutide","score":0.9980000257492065},{"id":"https://openalex.org/keywords/retatrutide","display_name":"retatrutide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/glucose-dependent-insulinotropic-polypeptide","display_name":"glucose-dependent insulinotropic polypeptide","score":0.8730000257492065},{"id":"https://openalex.org/keywords/glucagon","display_name":"glucagon","score":0.8029999732971191},{"id":"https://openalex.org/keywords/amylin","display_name":"amylin","score":0.9950000047683716},{"id":"https://openalex.org/keywords/obesity-treatment","display_name":"obesity treatment","score":0.7059999704360962},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.9150000214576721},{"id":"https://openalex.org/keywords/dual-agonist","display_name":"dual agonist","score":0.5649999976158142},{"id":"https://openalex.org/keywords/treatment-algorithm","display_name":"treatment algorithm","score":0.43799999356269836}],"concepts":[{"id":"https://openalex.org/C2780705028","wikidata":"https://www.wikidata.org/wiki/Q424643","display_name":"Amylin","level":4,"score":0.9005328416824341},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8512276411056519},{"id":"https://openalex.org/C2776398474","wikidata":"https://www.wikidata.org/wiki/Q424611","display_name":"Glucagon-like peptide-1","level":4,"score":0.6861160397529602},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6712394952774048},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6578258872032166},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6566376090049744},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.6197614669799805},{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.6190481185913086},{"id":"https://openalex.org/C185280430","wikidata":"https://www.wikidata.org/wiki/Q14909910","display_name":"Glucagon-like peptide 1 receptor","level":4,"score":0.5044964551925659},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.48827672004699707},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.45895084738731384},{"id":"https://openalex.org/C2778563252","wikidata":"https://www.wikidata.org/wiki/Q170617","display_name":"Glucagon","level":3,"score":0.4518274664878845},{"id":"https://openalex.org/C2778881409","wikidata":"https://www.wikidata.org/wiki/Q1420402","display_name":"Incretin","level":4,"score":0.42529773712158203},{"id":"https://openalex.org/C2780796126","wikidata":"https://www.wikidata.org/wiki/Q290293","display_name":"Peptide YY","level":5,"score":0.4103230834007263},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.2878624498844147},{"id":"https://openalex.org/C165220095","wikidata":"https://www.wikidata.org/wiki/Q207524","display_name":"Islet","level":3,"score":0.07795196771621704},{"id":"https://openalex.org/C118303440","wikidata":"https://www.wikidata.org/wiki/Q419968","display_name":"Neuropeptide","level":3,"score":0.051916152238845825},{"id":"https://openalex.org/C93984277","wikidata":"https://www.wikidata.org/wiki/Q24782073","display_name":"Neuropeptide Y receptor","level":4,"score":0.0}],"mesh":[{"descriptor_ui":"D000097789","descriptor_name":"Glucagon-Like Peptide-1 Receptor Agonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004763","descriptor_name":"Glucagon-Like Peptides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004763","descriptor_name":"Glucagon-Like Peptides","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D004763","descriptor_name":"Glucagon-Like Peptides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004763","descriptor_name":"Glucagon-Like Peptides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1080/14656566.2024.2356254","doi":"https://doi.org/10.1080/14656566.2024.2356254","is_oa":true,"landing_page_url":"https://doi.org/10.1080/14656566.2024.2356254","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/14656566.2024.2356254","source":{"id":"https://openalex.org/S52020611","display_name":"Expert Opinion on Pharmacotherapy","issn_l":"1465-6566","issn":["1465-6566","1744-7666"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Pharmacotherapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11195668","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11195668","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11195668/pdf/IEOP_25_2356254.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opin Pharmacother","raw_type":"Text"},{"id":"pmid:38753454","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38753454","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on pharmacotherapy","raw_type":"Journal Article"},{"id":"pmh:oai:figshare.com:article/26048686","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Oral_glucagon-like_peptide-1_receptor_agonists_and_combinations_of_entero-pancreatic_hormones_as_treatments_for_adults_with_type_2_diabetes_where_are_we_now_/26048686","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1080/14656566.2024.2356254","doi":"https://doi.org/10.1080/14656566.2024.2356254","is_oa":true,"landing_page_url":"https://doi.org/10.1080/14656566.2024.2356254","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/14656566.2024.2356254","source":{"id":"https://openalex.org/S52020611","display_name":"Expert Opinion on Pharmacotherapy","issn_l":"1465-6566","issn":["1465-6566","1744-7666"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Pharmacotherapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"},{"id":"https://openalex.org/F4320336903","display_name":"NIHR Leicester Biomedical Research Centre","ror":"https://ror.org/05xqxa525"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4396977424.pdf","grobid_xml":"https://content.openalex.org/works/W4396977424.grobid-xml"},"referenced_works_count":99,"referenced_works":["https://openalex.org/W807162506","https://openalex.org/W1533485972","https://openalex.org/W1773084519","https://openalex.org/W1957007052","https://openalex.org/W1970277737","https://openalex.org/W1975756049","https://openalex.org/W1975801154","https://openalex.org/W1982526723","https://openalex.org/W1987282451","https://openalex.org/W2021396934","https://openalex.org/W2027524238","https://openalex.org/W2032322539","https://openalex.org/W2045520194","https://openalex.org/W2084948079","https://openalex.org/W2115939390","https://openalex.org/W2151731752","https://openalex.org/W2157652680","https://openalex.org/W2162941228","https://openalex.org/W2215535790","https://openalex.org/W2302447233","https://openalex.org/W2319839537","https://openalex.org/W2337454357","https://openalex.org/W2519510391","https://openalex.org/W2581264645","https://openalex.org/W2762120405","https://openalex.org/W2885657542","https://openalex.org/W2901777059","https://openalex.org/W2909601957","https://openalex.org/W2919203803","https://openalex.org/W2990539453","https://openalex.org/W3011482816","https://openalex.org/W3012481772","https://openalex.org/W3014953461","https://openalex.org/W3045729180","https://openalex.org/W3083607789","https://openalex.org/W3099724881","https://openalex.org/W3102426258","https://openalex.org/W3119986206","https://openalex.org/W3123792142","https://openalex.org/W3124193412","https://openalex.org/W3127371223","https://openalex.org/W3127462604","https://openalex.org/W3133746780","https://openalex.org/W3177122952","https://openalex.org/W3177393241","https://openalex.org/W3191712049","https://openalex.org/W3192887403","https://openalex.org/W3202575491","https://openalex.org/W3205201678","https://openalex.org/W3211623221","https://openalex.org/W4200574551","https://openalex.org/W4205826195","https://openalex.org/W4206445899","https://openalex.org/W4210940103","https://openalex.org/W4213427170","https://openalex.org/W4221000750","https://openalex.org/W4224257527","https://openalex.org/W4224295659","https://openalex.org/W4281934192","https://openalex.org/W4283171904","https://openalex.org/W4283735616","https://openalex.org/W4285087957","https://openalex.org/W4292242922","https://openalex.org/W4292646864","https://openalex.org/W4296578151","https://openalex.org/W4296802076","https://openalex.org/W4304080455","https://openalex.org/W4308291843","https://openalex.org/W4309244706","https://openalex.org/W4310416488","https://openalex.org/W4310940908","https://openalex.org/W4311480480","https://openalex.org/W4317401374","https://openalex.org/W4319029388","https://openalex.org/W4319460325","https://openalex.org/W4321611198","https://openalex.org/W4353021269","https://openalex.org/W4362457850","https://openalex.org/W4377220176","https://openalex.org/W4381799391","https://openalex.org/W4381803348","https://openalex.org/W4381885413","https://openalex.org/W4381885429","https://openalex.org/W4381953497","https://openalex.org/W4382050932","https://openalex.org/W4382051781","https://openalex.org/W4382248917","https://openalex.org/W4385431101","https://openalex.org/W4385648883","https://openalex.org/W4386154055","https://openalex.org/W4387008365","https://openalex.org/W4387296976","https://openalex.org/W4388452162","https://openalex.org/W4388539816","https://openalex.org/W4389739323","https://openalex.org/W4391440666","https://openalex.org/W4391682062","https://openalex.org/W4392773706","https://openalex.org/W4393255879"],"related_works":["https://openalex.org/W7167572905","https://openalex.org/W4393184731","https://openalex.org/W4402038063","https://openalex.org/W2604623769","https://openalex.org/W4315490546","https://openalex.org/W4416049804","https://openalex.org/W2123041020","https://openalex.org/W3171499734","https://openalex.org/W2509773773","https://openalex.org/W2067104263"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Glucagon-like":[1],"peptide-1":[2],"(GLP-1)":[3],"receptor":[4],"agonists":[5,96],"(RAs)":[6],"have":[7,107],"changed":[8],"the":[9,31,40,80,125],"landscape":[10],"of":[11,42,54,168],"type":[12],"2":[13],"diabetes":[14],"(T2D)":[15],"management":[16,146],"due":[17],"to":[18,33],"their":[19,22,182,192,197],"cardio-renal":[20,183],"benefits,":[21,184],"glucose-lowering":[23],"efficacy":[24,186],"and":[25,51,65,72,91,93,133,156,176,187],"weight":[26],"loss":[27],"(WL)":[28],"maintenance.":[29],"However,":[30],"response":[32],"GLP-1":[34,43,49,55,85],"RA":[35],"monotherapy":[36],"is":[37,124],"heterogeneous.":[38],"Additionally,":[39],"majority":[41],"RAs":[44,50,86],"are":[45,67,116,139,170],"injectable":[46,52],"treatments.":[47],"Oral":[48],"combinations":[53],"with":[56,161,165],"other":[57,177],"entero-pancreatic":[58,148],"hormones":[59],"(glucose-dependent":[60],"insulinotropic":[61],"polypeptide":[62],"(GIP),":[63],"glucagon":[64],"amylin)":[66],"under":[68,171],"development":[69,172],"for":[70,113,131,158,173],"T2D":[71,114,132,145],"obesity":[73,134,175],"management.":[74,135],"AREAS":[75],"COVERED:":[76],"Herein,":[77],"we":[78],"review":[79],"data":[81],"on":[82,181],"(i)":[83],"oral":[84],"(oral":[87],"semaglutide":[88],"25/50":[89],"mg":[90],"orforglipron)":[92],"(ii)":[94],"dual/triple":[95],"(tirzepatide,":[97],"cagrilintide":[98],"2.4":[99,101],"mg/semaglutide":[100],"mg,":[102],"survodutide,":[103],"mazdutide,":[104],"retatrutide)":[105],"that":[106],"recently":[108],"completed":[109],"phase":[110,119],"3":[111,120],"trials":[112],"or":[115],"currently":[117],"in":[118,140,144,153,199],"clinical":[121],"trials.":[122],"Tirzepatide":[123],"first":[126],"approved":[127],"dual":[128],"agonist":[129],"(GLP-1/GIP)":[130],"EXPERT":[136],"OPINION:":[137],"We":[138],"a":[141],"new":[142],"era":[143],"where":[147],"hormone-based":[149],"treatments":[150],"can":[151],"result":[152],"\u226515%":[154],"WL":[155],"euglycemia":[157],"many":[159],"people":[160],"T2D.":[162],"Multiple":[163],"molecules":[164],"different":[166],"mechanisms":[167],"action":[169],"T2D,":[174],"metabolic":[178],"complications.":[179],"Data":[180],"long-term":[185],"safety":[188],"as":[189,191],"well":[190],"cost-effectiveness":[193],"will":[194],"better":[195],"inform":[196],"position":[198],"treatment":[200],"algorithms.":[201]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4396977424","counts_by_year":[{"year":2026,"cited_by_count":18},{"year":2025,"cited_by_count":13},{"year":2024,"cited_by_count":7}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2024-05-17T00:00:00"}
